Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study

Henrietta S. Bada, Abhik Das, Charles R Bauer, Seetha Shankaran, Barry Lester, Linda L. Wright, Joel Verter, Vincent L. Smeriglio, Loretta P. Finnegan, Penelope L. Maza

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

OBJECTIVE: To estimate the effects of cocaine exposure on intrauterine growth and to investigate at what point in gestation growth deviation would be manifested. METHODS: This is a secondary analysis of data from a multicenter project, the Maternal Lifestyle Study, designed to determine infant outcomes of in utero cocaine or opiates exposure. Four centers of the National Institute of Child Health and Human Development Neonatal Research Network enrolled 11,811 maternal-infant dyads. A total of 1072 infants were cocaine exposed, 7565 were cocaine negative by maternal history and meconium results, and 3174 were excluded from analysis because of unconfirmed negative exposure. Outcome measures included birth weight, length, and head circumference. RESULTS: Percentile estimates for birth weight, length, and head circumference revealed growth deceleration in cocaine-exposed infants evident after 32 weeks' gestation. There was significant interaction between cocaine and gestational age. After controlling for confounders, at 40 weeks' gestation, cocaine exposure was estimated to be associated with a decrease of 151 g, 0.71 cm, and 0.43 cm in birth weight, length, and head circumference, respectively. Smoking had a negative impact on all growth measurements, with some indication of a dose-effect relationship. Heavy alcohol use was associated with decrease in weight and length only. Opiates had significant effect only on birth weight. CONCLUSION: In utero cocaine exposure is associated with growth deceleration involving all measurements, becoming more pronounced with advancing gestation.

Original languageEnglish
Pages (from-to)916-924
Number of pages9
JournalObstetrics and Gynecology
Volume100
Issue number5
DOIs
StatePublished - Nov 1 2002

Fingerprint

Cocaine
Life Style
Mothers
Growth
Birth Weight
Opiate Alkaloids
Pregnancy
Deceleration
Head
National Institute of Child Health and Human Development (U.S.)
Meconium
Gestational Age
Smoking
Alcohols
Outcome Assessment (Health Care)
Weights and Measures
Research

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Bada, H. S., Das, A., Bauer, C. R., Shankaran, S., Lester, B., Wright, L. L., ... Maza, P. L. (2002). Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study. Obstetrics and Gynecology, 100(5), 916-924. https://doi.org/10.1016/S0029-7844(02)02199-3

Gestational cocaine exposure and intrauterine growth : Maternal lifestyle study. / Bada, Henrietta S.; Das, Abhik; Bauer, Charles R; Shankaran, Seetha; Lester, Barry; Wright, Linda L.; Verter, Joel; Smeriglio, Vincent L.; Finnegan, Loretta P.; Maza, Penelope L.

In: Obstetrics and Gynecology, Vol. 100, No. 5, 01.11.2002, p. 916-924.

Research output: Contribution to journalArticle

Bada, HS, Das, A, Bauer, CR, Shankaran, S, Lester, B, Wright, LL, Verter, J, Smeriglio, VL, Finnegan, LP & Maza, PL 2002, 'Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study', Obstetrics and Gynecology, vol. 100, no. 5, pp. 916-924. https://doi.org/10.1016/S0029-7844(02)02199-3
Bada, Henrietta S. ; Das, Abhik ; Bauer, Charles R ; Shankaran, Seetha ; Lester, Barry ; Wright, Linda L. ; Verter, Joel ; Smeriglio, Vincent L. ; Finnegan, Loretta P. ; Maza, Penelope L. / Gestational cocaine exposure and intrauterine growth : Maternal lifestyle study. In: Obstetrics and Gynecology. 2002 ; Vol. 100, No. 5. pp. 916-924.
@article{4f083373172143fca56ec2131d2da5d0,
title = "Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study",
abstract = "OBJECTIVE: To estimate the effects of cocaine exposure on intrauterine growth and to investigate at what point in gestation growth deviation would be manifested. METHODS: This is a secondary analysis of data from a multicenter project, the Maternal Lifestyle Study, designed to determine infant outcomes of in utero cocaine or opiates exposure. Four centers of the National Institute of Child Health and Human Development Neonatal Research Network enrolled 11,811 maternal-infant dyads. A total of 1072 infants were cocaine exposed, 7565 were cocaine negative by maternal history and meconium results, and 3174 were excluded from analysis because of unconfirmed negative exposure. Outcome measures included birth weight, length, and head circumference. RESULTS: Percentile estimates for birth weight, length, and head circumference revealed growth deceleration in cocaine-exposed infants evident after 32 weeks' gestation. There was significant interaction between cocaine and gestational age. After controlling for confounders, at 40 weeks' gestation, cocaine exposure was estimated to be associated with a decrease of 151 g, 0.71 cm, and 0.43 cm in birth weight, length, and head circumference, respectively. Smoking had a negative impact on all growth measurements, with some indication of a dose-effect relationship. Heavy alcohol use was associated with decrease in weight and length only. Opiates had significant effect only on birth weight. CONCLUSION: In utero cocaine exposure is associated with growth deceleration involving all measurements, becoming more pronounced with advancing gestation.",
author = "Bada, {Henrietta S.} and Abhik Das and Bauer, {Charles R} and Seetha Shankaran and Barry Lester and Wright, {Linda L.} and Joel Verter and Smeriglio, {Vincent L.} and Finnegan, {Loretta P.} and Maza, {Penelope L.}",
year = "2002",
month = "11",
day = "1",
doi = "10.1016/S0029-7844(02)02199-3",
language = "English",
volume = "100",
pages = "916--924",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Gestational cocaine exposure and intrauterine growth

T2 - Maternal lifestyle study

AU - Bada, Henrietta S.

AU - Das, Abhik

AU - Bauer, Charles R

AU - Shankaran, Seetha

AU - Lester, Barry

AU - Wright, Linda L.

AU - Verter, Joel

AU - Smeriglio, Vincent L.

AU - Finnegan, Loretta P.

AU - Maza, Penelope L.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - OBJECTIVE: To estimate the effects of cocaine exposure on intrauterine growth and to investigate at what point in gestation growth deviation would be manifested. METHODS: This is a secondary analysis of data from a multicenter project, the Maternal Lifestyle Study, designed to determine infant outcomes of in utero cocaine or opiates exposure. Four centers of the National Institute of Child Health and Human Development Neonatal Research Network enrolled 11,811 maternal-infant dyads. A total of 1072 infants were cocaine exposed, 7565 were cocaine negative by maternal history and meconium results, and 3174 were excluded from analysis because of unconfirmed negative exposure. Outcome measures included birth weight, length, and head circumference. RESULTS: Percentile estimates for birth weight, length, and head circumference revealed growth deceleration in cocaine-exposed infants evident after 32 weeks' gestation. There was significant interaction between cocaine and gestational age. After controlling for confounders, at 40 weeks' gestation, cocaine exposure was estimated to be associated with a decrease of 151 g, 0.71 cm, and 0.43 cm in birth weight, length, and head circumference, respectively. Smoking had a negative impact on all growth measurements, with some indication of a dose-effect relationship. Heavy alcohol use was associated with decrease in weight and length only. Opiates had significant effect only on birth weight. CONCLUSION: In utero cocaine exposure is associated with growth deceleration involving all measurements, becoming more pronounced with advancing gestation.

AB - OBJECTIVE: To estimate the effects of cocaine exposure on intrauterine growth and to investigate at what point in gestation growth deviation would be manifested. METHODS: This is a secondary analysis of data from a multicenter project, the Maternal Lifestyle Study, designed to determine infant outcomes of in utero cocaine or opiates exposure. Four centers of the National Institute of Child Health and Human Development Neonatal Research Network enrolled 11,811 maternal-infant dyads. A total of 1072 infants were cocaine exposed, 7565 were cocaine negative by maternal history and meconium results, and 3174 were excluded from analysis because of unconfirmed negative exposure. Outcome measures included birth weight, length, and head circumference. RESULTS: Percentile estimates for birth weight, length, and head circumference revealed growth deceleration in cocaine-exposed infants evident after 32 weeks' gestation. There was significant interaction between cocaine and gestational age. After controlling for confounders, at 40 weeks' gestation, cocaine exposure was estimated to be associated with a decrease of 151 g, 0.71 cm, and 0.43 cm in birth weight, length, and head circumference, respectively. Smoking had a negative impact on all growth measurements, with some indication of a dose-effect relationship. Heavy alcohol use was associated with decrease in weight and length only. Opiates had significant effect only on birth weight. CONCLUSION: In utero cocaine exposure is associated with growth deceleration involving all measurements, becoming more pronounced with advancing gestation.

UR - http://www.scopus.com/inward/record.url?scp=0036854112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036854112&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(02)02199-3

DO - 10.1016/S0029-7844(02)02199-3

M3 - Article

C2 - 12423853

AN - SCOPUS:0036854112

VL - 100

SP - 916

EP - 924

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -